Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A single combination gene therapy treats multiple age-related diseases.

Davidsohn N, Pezone M, Vernet A, Graveline A, Oliver D, Slomovic S, Punthambaker S, Sun X, Liao R, Bonventre JV, Church GM.

Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23505-23511. doi: 10.1073/pnas.1910073116. Epub 2019 Nov 4. Erratum in: Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):790.

2.

Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism.

Scheiman J, Luber JM, Chavkin TA, MacDonald T, Tung A, Pham LD, Wibowo MC, Wurth RC, Punthambaker S, Tierney BT, Yang Z, Hattab MW, Avila-Pacheco J, Clish CB, Lessard S, Church GM, Kostic AD.

Nat Med. 2019 Jul;25(7):1104-1109. doi: 10.1038/s41591-019-0485-4. Epub 2019 Jun 24.

PMID:
31235964
3.

Potent and long-lasting inhibition of human P2X2 receptors by copper.

Punthambaker S, Hume RI.

Neuropharmacology. 2014 Feb;77:167-76. doi: 10.1016/j.neuropharm.2013.09.001. Epub 2013 Sep 22.

4.

High potency zinc modulation of human P2X2 receptors and low potency zinc modulation of rat P2X2 receptors share a common molecular mechanism.

Punthambaker S, Blum JA, Hume RI.

J Biol Chem. 2012 Jun 22;287(26):22099-111. doi: 10.1074/jbc.M112.369157. Epub 2012 May 3.

5.

Active ADP-ribosylation factor-1 (ARF1) is required for mitotic Golgi fragmentation.

Xiang Y, Seemann J, Bisel B, Punthambaker S, Wang Y.

J Biol Chem. 2007 Jul 27;282(30):21829-37. Epub 2007 Jun 11.

Supplemental Content

Loading ...
Support Center